HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A case of Wernicke encephalopathy with hypoacusia and MR high intensity of the inferior colliculi that normalized after thiamine administration].

Abstract
A 61-year-old man was admitted to our institution with progressive hypoacusia, double vision, and lightheadedness. Neurological examination on day 6 of his illness showed severe hypoacusia, mild confusion, ocular motility disorder, truncal ataxia and absence of a deep tendon reflex. MRI fluid-attenuated inversion recovery imaging revealed symmetrical high intensities in the tectum of the midbrain, involving the bilateral inferior colliculi and the bilateral medial thalami, which suggested Wernicke encephalopathy (WE). Thiamine was administered immediately after completion of the MRI, and the patients' hearing and other abnormal neurologic signs improved rapidly within a few days, except for the absence of the deep tendon reflex. Whole blood examination at admission revealed very low levels of vitamin B1. The patient was discharged on day 19, and MRI on day 39 showed the disappearance of the abnormal high intensities involving the bilateral inferior colliculi. The present case indicates that hypoacusia and abnormal MRI signal due to WE might be normalized by administration of thiamine a few days after the onset of symptoms.
AuthorsTakuma Nakamura, Keisuke Imai, Masashi Hamanaka, Hidekazu Yamazaki, Takehiro Yamada, Toshiki Mizuno
JournalRinsho shinkeigaku = Clinical neurology (Rinsho Shinkeigaku) Vol. 58 Issue 2 Pg. 100-104 (Feb 28 2018) ISSN: 1882-0654 [Electronic] Japan
PMID29386493 (Publication Type: Journal Article)
Chemical References
  • Biomarkers
  • Thiamine
Topics
  • Biomarkers (blood)
  • Hearing Loss (drug therapy, etiology)
  • Humans
  • Inferior Colliculi (diagnostic imaging)
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Neuroimaging
  • Thiamine (administration & dosage, blood)
  • Treatment Outcome
  • Wernicke Encephalopathy (complications, diagnosis, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: